Progestasert - Drug Details
📊 Estimates Progestasert Dialyzability By Different_Modalities

Progestasert

Complete Drug Information

Drug Name
Progestasert
Trade Names
Prometrium, Utrogestan, Endometrin
Bioavailability
Oral: <2.4%Vaginal (micronized insert): 4–8%
Routes of Administration
Oral, sublingual, topical, vaginal, rectal, intramuscular, subcutaneous, intrauterine
Protein Binding
98–99%:• Albumin: 80%• CBGTooltip Corticosteroid-binding globulin: 18%• SHBGTooltip Sex hormone-binding globulin: <1%• Free: 1–2%%
Metabolism
Mainly liver:• 5α- and 5β-reductase• 3α-Tooltip 3α-Hydroxysteroid dehydrogenase and 3β-HSDTooltip 3β-Hydroxysteroid dehydrogenase• 20α-Tooltip 20α-Hydroxysteroid dehydrogenase and 20β-HSDTooltip 20β-Hydroxysteroid dehydrogenase• Conjugation• 17α-Hydroxylase• 21-Hydroxylase• CYPsTooltip CYP (e.g., CYP3A4)
Elimination
• Oral: 5 hours (with food)* Sublingual: 6–7 hours• Vaginal: 14–50 hours• Topical: 30–40 hours• IM: 20–28 hours• SC: 13–18 hours• IVTooltip Intravenous injection: 3–90 minutes
Excretion
Bile and urine
Formula
C21H30O2
Molar Mass
314.469
Melting Point
126 °C
Drug Class
Progestogen; Antimineralocorticoid; Neurosteroid
Volume of Distribution
C21H30O2